Test Review in Genetic Testing

The potential impact of genetic test misorders on patient care is broad and sometimes severe. Developing strategies to curtail this problem is critical to providing optimal patient care. A few studies have shown that an active utilization management (UM) program focused on a test review intervention can control the cost of genetic test misorders. However, little is known about the nature and types of misorders as well as the impact of a test review intervention on each type of misorder. Similarly, the potential effect of preventive interventions, such as consultation, remains largely unknown. This presentation will discuss Stanford’s genetic test stewardship effort to categorize misorders into five types to better measure the impact of the UM interventions implemented. In addition, we will demonstrate that the combined approach of test review and consultative service effectively reduced misorders over time and can positively influence healthcare providers’ behaviors.